NervGen Pharma Corp., a Vancouver-based company founded to develop regenerative-medicine technology licensed from Case Western Reserve University, raised about...
Only Ohio institution to receive funding all three years
The Ohio Third Frontier Commission has awarded Case Western Reserve University its third $500,000 gran...
Case Western Reserve University and Engine Biosciences Pte Ltd have signed an exclusive license option in which the drug discovery company will evaluate univers...
I-Corps@Ohio, an initiative from the Ohio Department of Higher Education, has expanded Case Western Reserve University, as well as Cleveland Clinic and Wright S...
Case Western Reserve University and NervGen Pharma Corp., based in Vancouver, have entered into an exclusive licensing agreement to research, develop and commer...
Technology developed by Case Western Reserve researchers; licensed by Technology Transfer Office
XaTek Inc., a Cleveland-based company developing a portable se...
Nanoparticle technology mimics blood platelets to prevent and treat bleeding from trauma, surgery
Case Western Reserve University and Haima Therapeutics LLC, a...
University Hospitals’ physicians to implement technology
Case Western Reserve University and Lucid Diagnostics, a subsidiary of publicly traded New York-based ...
I-Corps@Ohio program aims to advance research into products for medical treatments or surgeries
Four medical-technology research teams at Case Western Reserve ...
The Ohio Third Frontier Commission has awarded Case Western Reserve University an additional $500,000 grant for a campus-based translational research fund to he...
